Evaluation of D-dimer levels as a marker of chronic refractory urticaria and its correlation with disease severity


Original Article

Author Details : Tejinder Kaur*, Nikita Margam, Sukhraj Kaur

Volume : 10, Issue : 2, Year : 2024

Article Page : 171-175

https://doi.org/10.18231/j.ijced.2024.031



Suggest article by email

Get Permission

Abstract

Background: Chronic idiopathic urticaria (CIU) is very well managed by second-generation antihistamines in the majority of the cases but in a certain subset of patients symptoms persist despite their use. A deeper dig into disease pathogenesis will open new treatment options and better patient management.
Objectives: To evaluate D-Dimer as an anti-histaminic resistant chronic urticaria marker and its correlation with disease severity.
Materials and Methods: Forty chronic urticaria patients attending skin OPD were enrolled and divided into 2 groups of 20 patients each according to response to antihistamines. D-dimer levels were done in each patient.
Statistical analysis used: Unpaired t-test was used for assessing two groups and Pearsons correlation coefficient was used to find correlation between D-Dimer levels and Urticaria activity score over 7 days (UAS-7).Result- D-dimer levels were significantly higher in group 1(chronic refractory urticaria) as compared to group 2(chronic urticaria) and there is a positive correlation between D-dimer levels and urticaria activity score (UAS7).
Conclusion: Newer insights into alternative pathomechanism of chronic urticaria will open up new treatment options for treatment-resistant cases, this will lead to better patient management and improvement in quality of life.
 

Keywords: chronic refractory urticaria, D­dimer levels, treatment­resistant urticaria


How to cite : Kaur T, Margam N, Kaur S, Evaluation of D-dimer levels as a marker of chronic refractory urticaria and its correlation with disease severity. IP Indian J Clin Exp Dermatol 2024;10(2):171-175


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.







Article History

Received : 25-02-2024

Accepted : 13-03-2024


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijced.2024.031


Article Metrics






Article Access statistics

Viewed: 537

PDF Downloaded: 147



Medical Abbreviation List